EBR vs NOX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EBR

EBR SYSTEM CDI FORUS [EBR]

45LOW

NOX

NOXOPHARM FPO [NOX]

55MEDIUM

Score Breakdown

EBR NOX
Technical
47
46
Catalyst
55
50
Sentiment
50
50
Fundamental
42
39
Momentum
23
60
Risk Gate
42
46

Key Metrics

EBR Metric NOX
$175.7MMarket Cap$26.1M
2.8MAvg Volume (20d)168K
+0.1%Short InterestN/A
$1.47552-Week High$0.135
$0.36552-Week Low$0.046
-2.6%Daily Change+4.7%
$0.380Reference Price$0.089
-458.8%ROE-343.6%
N/AProfit Margin-161.7%

Active Signals

EBR Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Drifting lower — down 3.8% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (2.0 quarters)
EPS estimates revised downward (-10pts)
Near 52-week low (2% of range)

NOX Signals

MACD momentum is losing steam
Watch out — volume is flowing out even as price holds up. Distribution pattern
Drifting lower — down 6.8% over the last 5 days
Beating the Small Ords index — relative strength of 1.26, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Critical cash runway (0.1 quarters)
Moderate P/S ratio (7.7x)
Strong revenue growth (+50%)

Ask Scout AI to compare EBR and NOX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EBR vs NSB →EBR vs NTI →EBR vs NUZ →EBR vs NXN →EBR vs PAR →
EBR Full Analysis → NOX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).